Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered HCV E2 immunogens and related vaccine compositions

Engineered HCV E2 immunogens and related vaccine compositions

US Patent 11008368 · Granted May 18, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pan-neuraminidase inhibiting antibodies2025
Nanoparticle vaccines with novel structural components2025
Stabilized coronavirus spike (s) protein immunogens and related vaccines2025
Stabilized coronavirus spike (s) protein immunogens and related vaccines2025
Polypeptide having effect of inhibiting proliferation of leukemia cells2025
Thiazole compounds and methods of use thereof2025
Processes for preparing an FGFR inhibitor2025
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-2025
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (P2024
Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens2024
Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens2024
Stabilized hemagglutinin (HA) trimers as influenza vaccine antigens2024